Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06354530RecruitingPhase 2/Phase 3
Study of pre-surgery therapy for advanced esophageal cancer
This trial tests a combination of drugs (anlotinib, immunotherapy, and chemotherapy) given before surgery for esophageal cancer that has not spread to other organs. The goal is to see if this approach shrinks the tumor and improves outcomes.
Chongqing, None SelectedAges 18–80 - NCT06355154Recruiting
Moderate carbohydrate diet for pregnant women with diabetes
This study tests whether eating a moderate amount of carbohydrates (carbs) can help control blood sugar and improve pregnancy outcomes in women with diabetes who use insulin. If you are pregnant with one baby and use insulin for diabetes, this trial may help you find a balanced diet approach.
JerusalemAges 18–45 - NCT06356467Recruiting
How tumor and patient factors affect GEP-NEN treatment response
This study looks at how tumor and patient factors affect treatment response in well-differentiated GEP-NENs (neuroendocrine tumors of the digestive system). It may help doctors understand which treatments work best for people like you.
MilanAges 18 years+ - NCT06357403Recruiting
Predicting blood clots in ICU patients with a blood test
This study looks at whether a blood test measuring a substance called anti-factor Xa activity can help predict dangerous blood clots in critically ill patients. If you join, researchers will follow you to see if the test results can prevent clots.
Graz, StyriaAges 18 years+ - NCT06357741Recruiting
Desuzumab for knee osteoarthritis
This study tests a new medicine called Desuzumab for knee osteoarthritis. It looks at whether the medicine can help reduce pain and improve joint function.
Wuhan, HubeiAges 45–75 - NCT06358040Recruiting
Opioid dispenser after back surgery trial
This trial tests a special device that gives you pain medication (opioids) after back surgery, instead of a prescription. It may help you use just the right amount of pain medicine, and you'll use your smartphone for follow-up visits.
New York, New YorkAges 18 years+ - NCT06359418Recruiting
Acupuncture for prediabetes and obesity
This study tests whether acupuncture can help people with prediabetes and obesity manage their condition. If you have both higher-than-normal blood sugar and excess weight, this trial may offer a non-medication approach to improve your health.
BeijingAges 18–64 - NCT06359782RecruitingPhase 2
Testing C1-inhibitor for brain bleed after aneurysm
This trial tests a drug called C1-inhibitor (a protein that calms inflammation) given shortly after a bleeding stroke caused by an aneurysm. The goal is to see if it can reduce brain damage and improve recovery.
The Hague, South HollandAges 18 years+ - NCT06360393Recruiting
Checking inhaler use with a smart spacer for severe asthma on biologics
This trial tests if a smart spacer can help people with severe asthma use their inhaler correctly and stick to their medication schedule. It’s for adults already taking biologic drugs for asthma.
Zwolle, OverijsselAges 18 years+ - NCT06360471Recruiting
Preserving fertility in women with cancer
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Nanjing, JiangsuAges 20–40 - NCT06361225Recruiting
Routine RUSH protocol in the ICU
This study looks at what happens when ICU patients are checked every day with a simple ultrasound exam called the RUSH protocol. It may help doctors find problems earlier and improve care.
Kfar SabaAges 18–99 - NCT06361459Recruiting
Quit Smoking Before Spine Surgery
This study tests whether a program to help people quit smoking before spine surgery improves recovery. It's for adults having neck or low back surgery, but not for cancer or trauma cases.
Leiden, South HollandAges 18–75 - NCT06361238RecruitingPhase 3
Liraglutide to prevent confusion after heart surgery in seniors with diabetes
This trial is testing if liraglutide, a diabetes medication, can prevent delirium (sudden confusion) in older adults with type 2 diabetes who are having planned heart surgery. If you qualify, you may help find a new way to protect brain function after surgery.
Nanjing, JiangsuAges 60 years+ - NCT06361940RecruitingPhase 2
Short-term hormone therapy before breast cancer surgery
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
Milwaukee, WisconsinAges 18 years+ - NCT06362083Recruiting
Urethral stricture surgery database study
This study collects information from patients who have had surgery for a urethral stricture, which is a narrowing in the tube that carries urine out of the body. Being part of this study helps doctors learn more about different surgical treatments and their outcomes.
Graz, StyriaAges 18 years+ - NCT06362343Recruiting
Personalized dosing study for Xa inhibitor blood thinners
This study looks at how the body processes a certain type of blood thinner (Xa factor inhibitors) to help doctors find the right dose for each person. If you have a blood clot in your lungs and are on long-term treatment, this trial might help improve your care.
Beijing, Beijing MunicipalityAges 18–120 - NCT06362304Recruiting
New SPECT imaging for brain tumors
This trial tests a new imaging agent (99mTc-CNDG) to see if it can help doctors see brain tumors better on a SPECT/CT scan. It might provide more information than standard scans and could help guide treatment decisions.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06363006RecruitingPhase 1
Cardonizumab plus TKI for advanced liver cancer after prior treatment
This trial tests a combination of an immunotherapy drug (Cardonizumab) and a targeted therapy pill (TKI) for people with advanced liver cancer whose prior treatment has stopped working. The goal is to see if this second-line combination can help shrink tumors or slow the disease.
Beijing, Beijing MunicipalityAges 18–75 - NCT06363825RecruitingPhase 2
New combination therapy for advanced liver cancer
This trial tests a combination of treatments for advanced liver cancer: a targeted therapy (apatinib), an immunotherapy (camrelizumab), and two local treatments (TAE and HAIC). It may be an option if you have a high tumor burden or a tumor thrombus in the portal vein and haven't had systemic treatment before.
FuzhouAges 18–80 - NCT06363734RecruitingPhase 2
Targeted drug combo for EGFR-mutant lung cancer after resistance
This trial tests a combination of two targeted drugs (osimertinib and dalpiciclib) for people with advanced lung cancer whose tumors have a specific EGFR mutation and a change in the CDK4/6 pathway, and whose cancer has stopped responding to a third-generation EGFR targeted therapy. The goal is to see if this combination can help shrink tumors or slow cancer growth.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06364176RecruitingPhase 2
Adding losartan to improve Trikafta response in CF
This study tests whether adding the blood pressure medication losartan can help the standard CF drug Trikafta work better by reducing inflammation. It's for people with CF who still have high sweat chloride levels despite taking Trikafta.
Kansas City, KansasAges 12 years+ - NCT06364514Recruiting
Antibiotic course study for kids with complex medical needs
This study looks at how long children with complex medical conditions need to take antibiotics for pneumonia. The goal is to find a patient-centered approach to treatment that works best for each child.
Boston, MassachusettsAges 2–25 - NCT06364553Recruiting
Metal stent for swallowing problems from cancer
This study tests whether a metal tube (stent) placed in the esophagus can safely improve swallowing in people whose cancer blocks the food pipe and cannot be cured. It may help you eat and drink more comfortably.
Rotterdam, South HollandAges 18 years+ - NCT06365060Recruiting
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
This study is screening people with smoldering multiple myeloma or a monoclonal gammopathy to see if they might have an early form of AL amyloidosis, a condition where abnormal proteins build up in organs. If you meet the criteria, you will be tested to find out if you have amyloidosis, which could help catch it early.
Birmingham, AlabamaAges 40 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.